Goldman Sachs’s Direxion Daily S&P Biotech Bear 3X Shares LABD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $392K | Buy |
+52,358
| New | +$392K | ﹤0.01% | 4394 |
|
|
2025
Q1 | – | Sell |
-11,711
| Closed | -$84.9K | – | 5184 |
|
|
2024
Q4 | $84.9K | Sell |
11,711
-29,321
| -71% | -$213K | ﹤0.01% | 4800 |
|
|
2024
Q3 | $240K | Buy |
41,032
+3,099
| +8% | +$18.1K | ﹤0.01% | 4426 |
|
|
2024
Q2 | $278K | Buy |
37,933
+2,337
| +7% | +$17.1K | ﹤0.01% | 4248 |
|
|
2024
Q1 | $259K | Sell |
35,596
-177,546
| -83% | -$1.29M | ﹤0.01% | 4250 |
|
|
2023
Q4 | $2.07M | Sell |
213,142
-109,884
| -34% | -$1.06M | ﹤0.01% | 3187 |
|
|
2023
Q3 | $6.65M | Buy |
323,026
+234,185
| +264% | +$4.82M | ﹤0.01% | 2271 |
|
|
2023
Q2 | $1.28M | Buy |
88,841
+38,042
| +75% | +$547K | ﹤0.01% | 3471 |
|
|
2023
Q1 | $1.05M | Buy |
50,799
+5,452
| +12% | +$112K | ﹤0.01% | 3630 |
|
|
2022
Q4 | $782K | Buy |
+45,347
| New | +$782K | ﹤0.01% | 3833 |
|
|
2022
Q3 | – | Sell |
-9,579
| Closed | -$373K | – | 5582 |
|
|
2022
Q2 | $373K | Sell |
9,579
-13,206
| -58% | -$514K | ﹤0.01% | 4566 |
|
|
2022
Q1 | $799K | Sell |
22,785
-7,347
| -24% | -$258K | ﹤0.01% | 4273 |
|
|
2021
Q4 | $776K | Buy |
+30,132
| New | +$776K | ﹤0.01% | 4224 |
|
|
2018
Q1 | – | Sell |
-77
| Closed | -$71K | – | 4269 |
|
|
2017
Q4 | $71K | Hold |
77
| – | – | ﹤0.01% | 4005 |
|
|
2017
Q3 | $70K | Hold |
77
| – | – | ﹤0.01% | 4080 |
|
|
2017
Q2 | $106K | Buy |
+77
| New | +$106K | ﹤0.01% | 4127 |
|